Safety and Efficacy of Early Vitamin D Supplementation in Critically Ill Extremely Preterm Infants: An Ancillary Study of a Randomized Trial

被引:4
|
作者
Aristizabal, Natalia [1 ]
Holder, Mary Pat [1 ]
Durham, Leandra [1 ]
Ashraf, Ambika P. [1 ]
Taylor, Sarah [2 ]
Salas, Ariel A. [1 ,3 ]
机构
[1] Univ Alabama Birmingham, Dept Pediat, Birmingham, England
[2] Yale Univ, New Haven, CT USA
[3] Univ Alabama Birmingham Women & Infants Ctr, Suite 9380, 1700 6th Ave S, Birmingham, AL 35233 USA
关键词
Cholecalciferol; Neonates; Premature newborn; Racial disparities; Chronic lung disease; BRONCHOPULMONARY DYSPLASIA; DEFICIENCY; CALCIUM;
D O I
10.1016/j.jand.2022.06.012
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background Despite substantial evidence that vitamin D deficiency is highly prevalent among infants born extremely preterm (<28 weeks' of gestation), several consensus statements do not recommend vitamin D doses >400 IU/day for these infants. Safety remains a concern.Objective The study aim was to determine safety and efficacy profiles of enteral vitamin D in Black and White infants randomized to three different vitamin D doses soon after birth.Design Ancillary study of a masked randomized clinical trial. Participants/setting Seventy-three infants born extremely preterm between 2012 and 2015 at a southern US academic neonatal unit (33' latitude) who had >90% compliance with the assigned intervention were included.Intervention Infants were randomized to receive placebo (placebo group), 200 IU/day vitamin D (200 IU group), or 800 IU/day vitamin D (800 IU group) during the first 28 days after birth.Main outcome measures Safety outcomes included serum 25-hydroxy vitamin D (25 [OH]D) and calcium concentrations. Efficacy outcomes included the predictive risk of bronchopulmonary dysplasia. Statistical analysis Per-protocol analysis using unadjusted, repeated-measures mixed models.Results Mean birth weight was 815 + 199 g. Half were male and 56% were Black. Of 58 infants with 25(OH)D measurements at birth, 40 (69%) had vitamin D deficiency (<20 ng/mL). The mean difference in 25(OH)D in nanograms per milliliter between Postnatal Day 28 and Postnatal Day 1 was +9 in the placebo group, +23 in the 200 IU group, and +62 in the 800 IU group (P < 0.0001). The increase observed in 25(OH)D was more significant among Black infants. The predictive risk of severe bronchopulmonary dysplasia in the 200 IU and 800 IU groups was lower, but this difference did not reach statistical significance. No vitamin D or calcium toxicity was observed. Conclusions A vitamin D dose of 800 IU/day safely corrected vitamin D deficiency by Postnatal Day 14.J Acad Nutr Diet. 2023;123(1):87-94.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 50 条
  • [21] Multi-dose vitamin d supplementation in stable very preterm infants: Prospective randomized trial response to three different vitamin D supplementation doses
    Bozkurt, Ozlem
    Uras, Nurdan
    Sari, Fatma Nur
    Atay, Funda Yavanoglu
    Sahin, Suzan
    Alkan, Ayse Dogan
    Canpolat, Fuat Emre
    Oguz, Serife Suna
    EARLY HUMAN DEVELOPMENT, 2017, 112 : 54 - 59
  • [22] Platelet characteristics in extremely preterm infants after fatty acid supplementation: a randomized controlled trial
    Lundgren, Pia
    Pivodic, Aldina
    Nilsson, Anders K.
    Hellgren, Gunnel
    Danielsson, Hanna
    Wackernagel, Dirk
    Pupp, Ingrid Hansen
    Ley, David
    Savman, Karin
    Uhlen, Mattias
    Smith, Lois E. H.
    Hellstroem, Ann
    PEDIATRIC RESEARCH, 2024,
  • [23] Vitamin D supplementation of breastfed infants: a randomized dose–response trial
    Ekhard E. Ziegler
    Steven E. Nelson
    Janice M. Jeter
    Pediatric Research, 2014, 76 : 177 - 183
  • [24] Effects of early vitamin D supplementation on the prevention of bronchopulmonary dysplasia in preterm infants
    Ge, Haiyan
    Qiao, Yanxia
    Ge, Jun
    Li, Junran
    Hu, Kena
    Chen, Xiaohui
    Cao, Xinghua
    Xu, Xiangshi
    Wang, Wenzhe
    PEDIATRIC PULMONOLOGY, 2022, 57 (04) : 1015 - 1021
  • [25] Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
    Doerr, Jan
    Ohlraun, Stephanie
    Skarabis, Horst
    Paul, Friedemann
    TRIALS, 2012, 13
  • [26] EFFICACY OF VITAMIN D SUPPLEMENTATION IN THE TREATMENT OF FIBROMYALGIA: RANDOMIZED CONTROLLED TRIAL
    Abou-Raya, S.
    Abou-Raya, A.
    Helmii, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 295 - 295
  • [27] Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
    Jan Dörr
    Stephanie Ohlraun
    Horst Skarabis
    Friedemann Paul
    Trials, 13
  • [28] Efficacy of vitamin D supplementation in asthmatic children with vitamin D deficiency: A randomized controlled trial (ESDAC trial)
    Jat, Kana Ram
    Goel, Nancy
    Gupta, Nandita
    Gupta, Chandra Prakash
    Datta, Sudip
    Lodha, Rakesh
    Kabra, Sushil K.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, : 479 - 488
  • [29] Vitamin D Supplementation in Critically Ill Patients: A Meta-Analysis of Randomized Controlled Trials
    Singh, Sahib
    Sarkar, Sauradeep
    Gupta, Kushagra
    Rout, Amit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [30] Vitamin D supplementation of breastfed infants: a randomized dose-response trial
    Ziegler, Ekhard E.
    Nelson, Steven E.
    Jeter, Janice M.
    PEDIATRIC RESEARCH, 2014, 76 (02) : 177 - 183